Daniil Gataulin
Stock Analyst at Chardan Capital
(4.17)
# 1,565
Out of 4,630 analysts
75
Total ratings
40.3%
Success rate
18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintained: Buy | $21 → $23 | $9.19 | +150.27% | 3 | Jun 25, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $11 → $13 | $3.66 | +255.19% | 3 | Jun 17, 2026 | |
| CRVO CervoMed | Reiterated: Buy | $21 | $2.87 | +631.71% | 7 | May 17, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $36 → $35 | $13.07 | +167.79% | 2 | May 14, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | $51 → $53 | $12.63 | +319.64% | 3 | May 12, 2026 | |
| FBRX Forte Biosciences | Reiterated: Buy | $61 | $76.79 | -20.56% | 3 | May 11, 2026 | |
| KOD Kodiak Sciences | Upgraded: Buy | $14 → $61 | $45.37 | +34.45% | 6 | May 11, 2026 | |
| CGTX Cognition Therapeutics | Reiterated: Buy | $8 → $4 | $1.08 | +270.37% | 3 | May 8, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $5 → $7 | $1.28 | +446.88% | 8 | May 7, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $10 → $11 | $5.97 | +84.41% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $13.89 | +108.78% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $46.42 | -20.29% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $10.72 | +385.07% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $1.02 | -1.96% | 6 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $5.41 | +195.75% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $4.08 | +365.69% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.088 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.25 | n/a | 2 | Feb 15, 2023 |
Ocular Therapeutix
Jun 25, 2026
Maintained: Buy
Price Target: $21 → $23
Current: $9.19
Upside: +150.27%
Opus Genetics
Jun 17, 2026
Maintained: Buy
Price Target: $11 → $13
Current: $3.66
Upside: +255.19%
CervoMed
May 17, 2026
Reiterated: Buy
Price Target: $21
Current: $2.87
Upside: +631.71%
MeiraGTx Holdings
May 14, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $13.07
Upside: +167.79%
Oculis Holding AG
May 12, 2026
Reiterated: Buy
Price Target: $51 → $53
Current: $12.63
Upside: +319.64%
Forte Biosciences
May 11, 2026
Reiterated: Buy
Price Target: $61
Current: $76.79
Upside: -20.56%
Kodiak Sciences
May 11, 2026
Upgraded: Buy
Price Target: $14 → $61
Current: $45.37
Upside: +34.45%
Cognition Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $8 → $4
Current: $1.08
Upside: +270.37%
Ocugen
May 7, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $1.28
Upside: +446.88%
Zura Bio
May 7, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $5.97
Upside: +84.41%
May 6, 2026
Reiterated: Buy
Price Target: $29
Current: $13.89
Upside: +108.78%
May 5, 2026
Reiterated: Buy
Price Target: $37
Current: $46.42
Upside: -20.29%
Jan 28, 2026
Reiterated: Buy
Price Target: $52
Current: $10.72
Upside: +385.07%
Jan 2, 2026
Maintained: Hold
Price Target: $3 → $1
Current: $1.02
Upside: -1.96%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $5.41
Upside: +195.75%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $4.08
Upside: +365.69%
Jun 13, 2025
Maintained: Hold
Price Target: n/a
Current: $0.088
Upside: n/a
Feb 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $13.25
Upside: n/a